Product
TAK-925
1 clinical trial
1 indication
Indication
Idiopathic HypersomniaClinical trial
A Phase 1b Randomized, Double-Blind, Placebo-Controlled, Crossover Study of a Single Intravenous Infusion Dose of TAK-925 in Patients With Idiopathic HypersomniaStatus: Completed, Estimated PCD: 2020-11-19